| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 19.799 | 10.727 | 15.573 | 0 | 37.466 | 16.770 | 49.019 | 0 | 0 |
| Total Income - EUR | 0 | 19.799 | 10.727 | 16.450 | 93.034 | 37.466 | 16.770 | 49.019 | 0 | 33 |
| Total Expenses - EUR | 12.753 | 3.102 | 8.347 | 15.710 | 120.323 | 11.572 | 13.694 | 20.202 | 11.485 | 1.848 |
| Gross Profit/Loss - EUR | -12.753 | 16.697 | 2.379 | 740 | -27.289 | 25.895 | 3.076 | 28.817 | -11.485 | -1.815 |
| Net Profit/Loss - EUR | -12.753 | 16.103 | 1.512 | 585 | -28.220 | 25.558 | 2.928 | 28.339 | -11.485 | -1.815 |
| Employees | 0 | 0 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 0 |
Check the financial reports for the company - Edifarmavig Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 137 | 136 | 133 | 95.332 | 1.069 | 741 | 424 | 1.737 | 1.226 | 717 |
| Current Assets | 15.993 | 24.788 | 20.182 | 8.675 | 792 | 21.237 | 9.199 | 45.992 | 24.682 | 18.098 |
| Inventories | 25 | 24 | 24 | 75 | 74 | 538 | 526 | 527 | 526 | 523 |
| Receivables | 5.624 | 23.152 | 19.947 | 7.007 | 296 | 8.341 | 456 | 44.148 | 23.718 | 17.561 |
| Cash | 10.344 | 1.612 | 211 | 1.593 | 422 | 12.359 | 8.218 | 1.317 | 439 | 14 |
| Shareholders Funds | -13.054 | 3.182 | 4.958 | 5.474 | -22.852 | 3.139 | 5.998 | 34.254 | 3.513 | 1.678 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 29.185 | 21.742 | 15.357 | 98.960 | 30.083 | 24.107 | 10.799 | 15.905 | 24.819 | 19.546 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7022 - 7022" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Edifarmavig Srl